ASLE
AerSale Corporation
ASLE has lower modeled downside risk, despite its lower overall score.
RKLB
Rocket Lab USA, Inc.
RKLB has the edge over ASLE overall, supported by stronger fundamentals and stronger modeled upside.
ASLE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Weak | |
| Weak |
ASLE's revenue is currently stable, but its profitability, cash flow and balance sheet are weak.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
ASLE PE Valuation
ASLE has no meaningful PE right now: it lost money over the past year.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
ASLE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong decline | |
| Stable | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect ASLE's earnings and profitability to decline, with its revenue holding steady.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
RKLB has the edge over ASLE on the outlook, with more favorable earnings and revenue expectations.
ASLE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.27 | — |
| Q3 2026 | -$0.40 | -408% |
| Q2 2026 | -$0.09 | -164% |
| Q1 2026 | $0.21 | +$0.32 |
| Q4 2025 | $0.18 | +64% |
| Q3 2025 | $0.13 | +$0.14 |
| Q2 2025 | $0.14 | +$0.16 |
| Q1 2025 | -$0.11 | -$0.08 |
| Q4 2024 | $0.11 | +$0.26 |
ASLE has the edge over RKLB on earnings, with more consistent year-over-year improvement.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
ASLE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $91.6M | +29% |
| Q2 2026 | $70.9M | -34% |
| Q1 2026 | $70.6M | +7.4% |
| Q4 2025 | $90.9M | -4% |
| Q3 2025 | $71.2M | -14% |
| Q2 2025 | $107.4M | +39% |
| Q1 2025 | $65.8M | -27% |
| Q4 2024 | $94.7M | +0.3% |
ASLE's revenue is recovering but still below its 2022 peak: $92M last quarter, up 29% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -13% | -17 points |
| Q2 2026 | -6.7% | -18 points |
| Q1 2026 | -4.7% | +5.4 points |
| Q4 2025 | 7.8% | +2.5 points |
| Q3 2025 | 4% | +1.6 points |
| Q2 2025 | 12% | +14 points |
| Q1 2025 | -10% | -15 points |
| Q4 2024 | 5.2% | +6.3 points |
ASLE has the edge over RKLB on profitability, with a higher operating margin.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB has the edge over ASLE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB's operating margin was −30% last quarter, up 8.5 points from the same quarter a year ago.
ASLE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$11.1M | -$1.3M |
| Q2 2026 | -$7.6M | -141% |
| Q1 2026 | -$27.7M | +$19.9M |
| Q4 2025 | $9.8M | -70% |
| Q3 2025 | -$9.8M | -211% |
| Q2 2025 | $18.6M | +$37.6M |
| Q1 2025 | -$47.6M | -$22.6M |
| Q4 2024 | $32.3M | +$41.9M |
ASLE has burned cash in most quarters: −$37M over the past year, against −$7M the year before.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
ASLE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.8% | +377K shares |
| 1 year | +1.2% | +544K shares |
| 3 years | -7% | -3.6M shares |
| 5 years | +12% | +5.1M shares |
ASLE has the edge over RKLB on shareholder dilution, with a more favorable share count trend.
RKLB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.6% | +22.6M shares |
| 1 year | +23% | +124M shares |
| 3 years | +35% | +168M shares |
| 5 years | +46% | +204M shares |
RKLB has 652M diluted shares, up 23% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
ASLE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 15.1x | High |
| Q2 2026 | 6.2x | High |
| Q1 2026 | 3.5x | Elevated |
| Q4 2025 | 3.1x | Elevated |
| Q3 2025 | 3.7x | Elevated |
| Q2 2025 | 3.5x | Elevated |
| Q1 2025 | 7.8x | High |
| Q4 2024 | 1.4x | Healthy |
ASLE's net debt is about 15 years of its operating earnings (EBITDA), up from 3.7 years a year ago.
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ASLE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 20.4 | Neutral |
ASLE's weekly RSI is 42 (neutral) and its Stochastic is 20 (neutral).
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
ASLE PE vs Industrials Sector
| Metric | ASLE | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
ASLE has no meaningful PE right now: it lost money over the past year.
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
ASLE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.94 | 4% above |
| 20 week MA | $5.51 | 6.7% below |
| 50 week MA | $6.30 | 18% below |
| 100 week MA | $6.63 | 22% below |
| 200 week MA | $8.96 | 43% below |
ASLE has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 43% below its 200-week average.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB has the edge over ASLE on trend strength, trading above more of its moving averages.
ASLE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.2 | $11.9 | +17% |
| 2021 | $11.9 | $17.3 | +46% |
| 2022 | $17.3 | $15.4 | -11% |
| 2023 | $15.4 | $12.7 | -17% |
| 2024 | $12.7 | $6.13 | -52% |
| 2025 | $6.13 | $7.11 | +16% |
| 2026 YTD | $7.11 | $5.14 | -28% |
ASLE has finished lower in three of the last six years. It's down 28% so far in 2026.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB has the edge over ASLE on returns for 2026, with the stronger performance.